Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2022

Summary of Significant Accounting Policies

Schedule of incentive and tax receivables

	September 30,		December 31,
	2022		2021
Research and development incentive (non-AOF) for the period 1/1/18 - 12/31/18	$	—	$	3,144,152
Research and development incentive (non-AOF) for the period 1/1/19 - 12/31/19		—		2,914,931
Research and development incentive (non-AOF) for the period 1/1/20 - 12/31/20		—		1,993,038
Research and development incentive (non-AOF) for the period 1/1/21 - 12/31/21		1,095,535		1,226,688
Research and development incentive (AOF) for the period 1/1/18 - 12/31/19		—		8,566,843
Goods and services tax		283,203		301,659
Total incentive and tax receivables before reserve for AOF		1,378,738		18,147,311
Reserve for research and development incentive (AOF) for the period 1/1/18 - 12/31/19		—		(8,566,843)
Total incentive and tax receivables - current assets	$	1,378,738	$	9,580,468

Schedule of research and development expenses

	Nine months ended September 30,
	2022		2021
Research and development expenses - before R&D incentive	$	16,450,619	$	17,304,684
Research and development incentive		(818,469)		(902,555)
Total research and development expenses	$	15,632,150	$	16,402,129

Summary of potentially dilutive securities excluded from the computation of diluted weighted average shares outstanding

	September 30,
	2022	2021
Stock options	6,276,016	5,300,538
Unvested restricted stock	2,119,512	1,053,822
	8,395,528	6,354,360